E-LIB Suche - Ergebnisse für: Savas, Peter

1

Annotation-efficient deep learning for breast cancer whole-..:

Perera, Rashindrie ; Savas, Peter ; Senanayake, Damith...
Communications Engineering. 3 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

The anti-cancer immune response in breast cancer: current a..:

Rayson, Victoria C. ; Harris, Michael A. ; Savas, Peter...
Trends in Cancer. 10 (2024) 6 - p. 490-506 , 2024

Link: https://doi.org/10.1016/..

3

CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated neg..:

House, Imran G. ; Derrick, Emily B. ; Sek, Kevin...
Cell Reports. 43 (2024) 2 - p. 113793 , 2024

Link: https://doi.org/10.1016/..

4

Towards targeting the breast cancer immune microenvironment:

Harris, Michael A. ; Savas, Peter ; Virassamy, Balaji...
Nature Reviews Cancer. 24 (2024) 8 - p. 554-577 , 2024

Link: https://doi.org/10.1038/..

5

Tucatinib promotes immune activation and synergizes with pr..:

Li, Ran ; Sant, Sneha ; Brown, Emmaline...
JNCI: Journal of the National Cancer Institute. 115 (2023) 7 - p. 805-814 , 2023

Link: https://doi.org/10.1093/..

6

Intratumoral CD8+ T cells with a tissue-resident memory phe..:

Virassamy, Balaji ; Caramia, Franco ; Savas, Peter...
Cancer Cell. 41 (2023) 3 - p. 585-601.e8 , 2023

Link: https://doi.org/10.1016/..

7

CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated neg..:

House, Imran G. ; Derrick, Emily B. ; Sek, Kevin...
Cell Reports. 42 (2023) 8 - p. 113014 , 2023

Link: https://doi.org/10.1016/..

8

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet fo..:

Schmid, Peter ; Turner, Nicholas C. ; Barrios, Carlos H....
Clinical Cancer Research. 30 (2023) 4 - p. 767-778 , 2023

Link: https://doi.org/10.1158/..

9

Combined PARP and WEE1 inhibition triggers anti-tumor immun..:

Teo, Zhi Ling ; O'Connor, Mark J. ; Versaci, Stephanie...
npj Breast Cancer. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Combining Radiotherapy and Immunotherapy in Metastatic Brea..:

David, Steven ; Tan, Jennifer ; Siva, Shankar...
Biomedicines. 10 (2022) 4 - p. 821 , 2022

Link: https://doi.org/10.3390/..

11

Correction to: Clinical implications of prospective genomic..:

van Geelen, Courtney T. ; Savas, Peter ; Teo, Zhi Ling...
Breast Cancer Research. 24 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

12

Seeing the forest and the tree: TILs and PD-L1 as immune bi..:

Savas, Peter ; Salgado, Roberto ; Loi, Sherene
Breast Cancer Research and Treatment. 189 (2021) 3 - p. 599-606 , 2021

Link: https://doi.org/10.1007/..

13

A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phen..:

Sarkar, Sunit ; Tran, Ben ; Horvath, Lisa...
Cancer Chemotherapy and Pharmacology. 87 (2021) 5 - p. 613-620 , 2021

Link: https://doi.org/10.1007/..

14

Validation and characterisation of prognostically significa..:

Young, Richard J. ; Bressel, Mathias ; Porceddu, Sandro...
Oral Oncology. 101 (2020) - p. 104516 , 2020

Link: https://doi.org/10.1016/..

15

Clinical implications of prospective genomic profiling of m..:

van Geelen, Courtney T. ; Savas, Peter ; Teo, Zhi Ling...
Breast Cancer Research. 22 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..